retatrutide and menstrual cycle UK Guide: Key Facts on the New Weight-Loss Drug 30 Days of Retatrutide —

Manzi explains that highlighting health risks and comorbidities, such as prediabetes, metabolic syndrome, hypertension, or other cardiovascular issues like heart disease or impaired glucose tolerance, can strengthen the case for medical necessity

It is important to note that patients with a history of major depression were actually excluded from the phase 3 randomized controlled trials (RCTs) of these medications 10,11,12,13,14,15,21,22,23

Sources: NICE NG12: Suspected cancer (recognition and referral for suspected cancer)

Roux-en-Y gastric bypass increases glycemic excursions during pregnancy and postpartum: A prospective cohort study